4.5 Musculoskeletal effects T2DM raises the risk of fractures, poor bone repair, and other factors that lead to brittle bones (64)
Depending on the formulation and dose, pills may be somewhat less effective than weekly injections but still provide meaningful weight-loss results
Bacterial contamination produces endotoxins (lipopolysaccharide fragments from bacterial cell walls) that remain in solution even if you discard the vial later
What the evidence supports: BPC-157 consistently improves tendon healing outcomes in animal models across multiple tissue types and injury models TB-500 accelerates wound healing and tissue repair in preclinical studies with measurable improvements in re-epithelialization, collagen deposition, and angiogenesis GHK-Cu enhances collagen synthesis and modulates thousands of genes involved in tissue repair GHRP-2 shifts macrophage polarization favorably in a rotator cuff tear model Relaxin-2 eliminates capsular fibrosis in a frozen shoulder mouse model No significant toxicity has been identified in preclinical BPC-157 studies What remains uncertain: Whether animal study results translate to equivalent human outcomes for shoulder conditions specifically Optimal dosing for human shoulder injuries (all protocols are extrapolated from animal data and clinical observation) Long-term safety with repeated use Whether peptides meaningfully reduce rotator cuff retear rates after surgical repair in humans How peptide therapy compares to established treatments like PRP in controlled human studies Potential interactions with medications commonly used by shoulder pain patients What we need: Randomized controlled trials of BPC-157 and TB-500 for specific shoulder conditions in humans Head-to-head comparisons of peptide therapy versus established treatments Long-term safety data from monitored human use Standardized dosing protocols based on human pharmacokinetic data Studies combining peptides with rehabilitation to assess synergistic effects The preclinical evidence is compelling
16,17 Hence, mechanistic studies indicate that oral semaglutide parks in the stomach, where it is then absorbed in a localized fashion with the help of the absorption enhancer sodium N -[8 (2-hydroxylbenzoyl) amino] caprylate (SNAC)
A clinician who repeats those figures to a patient is setting up a disappointment and a refund request
